126 DRUGS ARE IN ALZHEIMER’S clinical trials. “Every single one represents hope,” according to Closing in on a Cure: Alzheimer’s Clinical Trials Report. Read the
In the lab, fujimycin slowed Alzheimer’s. (Fujimycin is an organ-transplant drug also called FK506 or Tacrolimus.) In past studies, similar drugs, like rapamycin and ciclosporin,
DRUG RESEARCH VIDEO + ARTICLE: This FDA-approved anti-epileptic medication benefits Alzheimer’s in the lab. Learn about the promising research.
Geneticists have discovered a promising direction in Huntington’s treatment. In the lab, glutathione peroxidase improved Huntington’s disease. Drugs mimicking this activity are already approved for
MEDICATION & TREATMENT VIDEO: Agitation is one of the most common symptoms of Alzheimer’s. See why citalopram may be effective in alleviating Alzheimer’s agitation and
MEDICATION: New insights in using Alzheimer’s drugs for other memory problems shows why these medications are no simple memory patch.
REVIEW – PROGRESS THROUGH RESEARCH – VIDEO & ARTICLE: Alzheimer’s may be triggered by brain immune-system imbalances. Learn the way Duke University researchers want to
MEDICATION & MOOD: Aggression and agitation are hard challenges in dementia. An important study may offer some simple answers.
OFF-LABEL DRUGS, VIDEO & ARTICLE: The American Heart Association reports the blood pressure drug nilvadipine increases blood flow to the brain’s memory and learning center.
In a first-of-its-kind study, FDA-Approved Dantrolene, a muscle relaxant, was delivered through the nose to Alzheimer’s lab animals. It eased their Alzheimer’s by providing therapeutic
UCLA researchers found active people build 5% more gray matter in their brain. See how this prevents Alzheimer’s.
Learn about The Alzheimer’s Society of Canada’s campaign to bust the stigma of dementia.
Discover 6 easy ways you can make a difference.
WellnessCheck is a brief, friendly assessment, designed to help you understand your current cognitive wellness. It takes about 3 minutes and covers memory, mood, and focus.
Alzheimer’s is the most common type of dementia, but it is just one cause. In this short Q & A, watch Stanford Neurologist Dr. Kerchner explain the importance of getting an accurate diagnosis.
The “glymphatic system” removes brain waste. It may be a powerful new target to treat Alzheimer’s. Learn why scientists believe Alzheimer’s may arise when the system is not doing its cleaning properly.
Plaques are the best-known Alzheimer’s culprit. Cambridge scientists have figured out the 7 steps to forming these plaques. Find out how targeting the formation of these “oligomers” may hold the key to a cure.
UCLA researchers found active people build 5% more gray matter in their brain. See how this prevents Alzheimer’s.
No spam, only news and updates.
